ResorBone™ Is Officially Certified in Ukraine

2 Apr 2026

biodrook at ASIR Conference: 3D Implants & Clinical Collaboration

The biodrook team recently participated in the ASIR Conference — a key professional event that brings together leading experts in traumatology and orthopedics from across Ukraine.
For us, this was not only an opportunity to present our solutions, but also to engage in meaningful dialogue with clinicians who work with complex cases on a daily basis.
During the conference, we had the opportunity to connect with practicing surgeons, discuss current challenges in trauma care, and explore how personalized 3D-printed implants can be integrated into real clinical workflows. These conversations are essential for us. They allow us to better understand the needs of the medical community and ensure that our solutions are aligned with real-world practice.

We are especially grateful for the positive feedback from the conference organizer, Professor Mykola Ankin, MD, PhD, whose expertise and leadership play a significant role in advancing traumatology and orthopedics in Ukraine. We highly value the opportunity to exchange perspectives and discuss potential directions for future collaboration.

The ASIR Conference also became a platform for building new professional relationships. We established connections with a number of specialists and are currently continuing communication, including follow-up discussions and preparation for upcoming presentations. This ongoing engagement is a key part of how we build long-term partnerships and bring innovation closer to clinical practice.

We would like to sincerely thank the ASIR organizers for creating a high-level professional environment that fosters knowledge exchange, collaboration, and development within the medical community. Events like this are essential for driving progress in modern medicine.

At biodrook, we remain committed to developing and implementing personalized regenerative solutions that address real clinical needs. We look forward to continuing the dialogue and strengthening our collaboration with the medical community.

05 Sep 2025

biodrook has received DSTU EN ISO 13485:2018 certification

A new stage of responsibility and trust in the production of medical devices

We are pleased to announce that the company biodrook has successfully passed certification for compliance with the international standard DSTU EN ISO 13485:2018 — one of the highest industry standards in the field of development and production of medical devices.

What is ISO 13485 and why is it important?

ISO 13485 is an international quality management standard specifically created for medical devices. It regulates all stages of the product life cycle: from design, development, and production — to post-market monitoring, traceability, and user feedback.

Obtaining this certificate means that biodrook’s production processes comply with international safety and quality requirements, and all products undergo proven quality control and risk management procedures. At biodrook, a transparent system of documentation, change tracking, and accountability has been established.

Why is this important for doctors, partners, clinics, and patients?

This certification is not just a formality. It is a guarantee of trust:

For clinics and doctors — confidence in the quality of implants and related solutions
For international partners — compliance with global requirements, simplification of import procedures and joint projects
For investors — confirmation of the maturity of internal processes and readiness for scaling
For the state — an example of implementing a new generation of quality medical infrastructure

Our approach is not formal, but systemic.
We did not just “receive a certificate”. We have implemented a culture of quality that covers every step — from the first sketch to the sterile packaging of the finished product. The focus is on the patient, their safety, comfort, and quality of life.

This achievement became possible thanks to the biodrook team — engineers, technologists, quality specialists, and administrative staff. Their dedication, precision, and strategic vision shape the future of the Ukrainian medtech industry every day.

We also sincerely thank our partners, advisors, and the certification body for their support and professional guidance.

What’s next?
This is only one of the steps. Ahead — product certification, entry into the Ukrainian market, new products and markets, and new challenges. But the foundation has already been laid. And we are ready to move forward.

biodrook — developing the medicine of the future. In Ukraine. For the world.

Learn more about the technology and application of custom implants at biodrook.com
Contact the team: moc.koordoib%40ofni